Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: Box-By-The-Riviera™ who wrote (214902)	6/16/2025 12:25:37 AM
From: TobagoJack	Respond to of 217587

re <<think>> ... even as we get concerned about dire AI, we must get doubly troubled by EI (enhanced intelligence) bloomberg.com China Joins US in Brain Implant Race With Clinical Trial By Karoline Kan June 16, 2025 at 11:10 AM GMT+8 China has successfully conducted its first clinical trial of a brain-computer interface (BCI) technology, allowing a patient with tetraplegia to control electronic devices with their mind. Summary by Bloomberg AI The implant used in the trial is the world's smallest, with a diameter of 26 millimeters and thickness less than 6 millimeters, and is over 100 times more flexible than the one developed by Neuralink. Summary by Bloomberg AI The team plans to enable the patient to operate a robotic arm using thoughts to perform complex physical actions, and the BCI system could get approval and enter the market as early as 2028. Summary by Bloomberg AI China’s first clinical trial of a technology that allows signals from the brain to control an external device has proved successful, making it only the second country after the US to reach this stage, according to the Global Times. Chinese researchers used brain-computer interfaces, or BCI, a wireless invasive implant in a patient with tetraplegia in March, the English-language newspaper reported. Only a few weeks after the surgery, the patient was able to play racing games and chess on the computer using only the mind to control the electronic devices, it said, citing a statement from the Shanghai-based Center for Excellence in Brain Science and Intelligence Technology. BCI is an emerging technology to help restore functionality to people with paralysis, and Neuralink Corp., co-founded by Elon Musk, is at the forefront of this research. The implant used in the Chinese trial is the world’s smallest so far, with a diameter of 26 millimeters and thickness less than 6 millimeters, the Global Times said, adding that it’s over 100 times more flexible than the one developed by Neuralink. For the next stage, the team plans to enable the patient to operate a robotic arm using thoughts to perform more complex physical actions as such grasping and holding a cup. The center launched the trial in collaboration with Fudan University’s Huashan Hospital. Beijing has reported some experiments with implants by startup companies over the past months, but the clinical trial shows China is in a tight race with the US in developing this frontier technology. The center said the BCI system could get approval from the authorities, and be able to enter the market as early as 2028.

To: Box-By-The-Riviera™ who wrote (214902)	6/16/2025 12:30:01 AM
From: TobagoJack	1 Recommendation Recommended By Cactus Jack Respond to of 217587

re <<might be market moving>> looking like hints of ZIRP as 'they' are at it again bloomberg.com